Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.3M Buy
195,668
+39,935
+26% +$3.22M 0.15% 128
2026
Q1
$13.5M Buy
155,733
+141,702
+1,010% +$13.6M 0.18% 113
2025
Q4
$1.35M Sell
14,031
-2,049
-13% -$199K 0.02% 333
2025
Q3
$1.53M Sell
16,080
-36,546
-69% -$3.36M 0.02% 311
2025
Q2
$4.59M Sell
52,626
-120,640
-70% -$10.2M 0.06% 206
2025
Q1
$15.6M Sell
173,266
-195,854
-53% -$17.5M 0.24% 94
2024
Q4
$29.5M Buy
369,120
+58,173
+19% +$5.04M 0.4% 53
2024
Q3
$28M Buy
310,947
+267,144
+610% +$22.5M 0.42% 49
2024
Q2
$3.45M Buy
43,803
+13,369
+44% +$1.1M 0.14% 130
2024
Q1
$2.65M Sell
30,434
-404,306
-93% -$34.5M 0.11% 154
2023
Q4
$35.8M Buy
434,740
+10,843
+3% +$826K 0.79% 28
2023
Q3
$33.2M Buy
423,897
+33,361
+9% +$2.79M 0.74% 34
2023
Q2
$34.4M Buy
390,536
+34,028
+10% +$2.93M 0.81% 31
2023
Q1
$28.7M Buy
+356,508
New +$29.1M 0.73% 33

Other funds holding MDT

LBP AM's MDT Position: Q2 2026 in Review

LBP AM increased its Medtronic (MDT) stake by 26% in Q2 2026, buying an estimated $3.22M and bringing the position to 195,668 shares worth $15.3M. The position accounts for 0.15% of the portfolio, ranked #128.

LBP AM first reported a position in MDT in Q1 2023 and has held it in 14 quarters since. The position peaked at $35.8M in Q4 2023. 2,137 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • LBP AM held 195,668 shares of Medtronic worth $15.3M as of Q2 2026.
  • LBP AM bought 39,935 Medtronic shares in Q2 2026, an estimated $3.22M.
  • Medtronic made up 0.15% of LBP AM's portfolio in Q2 2026, its #128 holding.
  • LBP AM first reported a position in Medtronic in Q1 2023 and has held it in 14 quarters since.
  • LBP AM's Medtronic position peaked at $35.8M in Q4 2023.
  • 2,137 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on LBP AM's 13F filing for Q2 2026, filed 24 Jul 2026.